Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Exciting Additions to Goodwin’s Data + Privacy + Cybersecurity Group

Related Content

Congress Considers New Cybersecurity Legislation Adjunct to HIPAA

The NIS 2 Era Is Here: Are You Compliance-Ready?

Irish Data Protection Commission fines LinkedIn Ireland EUR 310 million for GDPR violations

Four Steps to Maximize the Value of AI Innovation in Medtech

How the EU AI Act Could Affect Medtech Innovation

NYDFS Publishes Guidance on AI-Related Cybersecurity Risks

Latest EDPB Opinion: What You Need to Know About Using Processors and Sub-Processors

SEC Rulemaking Returns After Quiet Stretch: Assessing the SEC “Reg. Flex” Agenda for BDs and Exchanges

Goodwin CLE Week 2025

AlloVir and Kalaris Therapeutics to Merge

Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas

Goodwin Advises HLTH in its Acquisition by Hyve

Goodwin UK Highly Ranked in Chambers UK 2025

Why Cyber Best Practice and Data Governance Is Not a One-Time Exercise (Nasdaq Trade Talks)

Goodwin Advises Curon Biopharmaceutical in Acquisition of CN201 by Merck for $700 Million Upfront Plus up to $600 Million Milestones

The Legal 500 UK 2025 Recognizes 26 Practices and 39 Lawyers Across Goodwin’s UK Platform

Data, Privacy & Cybersecurity